DAX22.462 -1,0%ESt505.331 -0,9%Top 10 Crypto12,01 -1,5%Dow41.584 -1,7%Nas17.323 -2,7%Bitcoin77.279 -0,4%Euro1,0827 ±-0,0%Öl73,38 -0,9%Gold3.083 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Tesla A1CX3T NVIDIA 918422 RENK RENK73 HENSOLDT HAG000 Novo Nordisk A3EU6F Mercedes-Benz Group (ex Daimler) 710000 Volkswagen (VW) vz. 766403 Lufthansa 823212 thyssenkrupp 750000 Porsche PAG911 BYD A0M4W9 Commerzbank CBK100 Amazon 906866 DEUTZ 630500
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Börsen mit tiefrotem Wochenausklang -- DAX geht schwächer ins Wochenende -- CureVac mit Erfolg im Patentstreit mit BioNTech -- CoreWeave-IPO, NEL, RENK, Novo Nordisk, Deutsche Bank, IONOS im Fokus
Top News
Top-News der Woche: Diese Themen waren diese Woche wichtig Top-News der Woche: Diese Themen waren diese Woche wichtig
US-Aktien überbewertet? - Diese Anzeichen deuten darauf hin US-Aktien überbewertet? - Diese Anzeichen deuten darauf hin
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Bis zu 3,05 % Zinsen: Jetzt die besten Tagesgeld-Angebote checken

Moderna Aktie

NeuKaufenVerkaufen
Moderna Aktien-Sparplan
28,57 EUR -1,43 EUR -4,75 %
FSE
31,01 USD -0,11 USD -0,35 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.11,45 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2N9D9

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS60770K1079

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolMRNA

Moderna Aktien News

DatumMeistgelesen
PR NewswireCarisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
PR NewswireCarisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
PR NewswireFlagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
Wer­bungModerna-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireShareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA
PR NewswireInvaio Sciences Appoints André Andonian as Chairman of the Board of Directors
PR NewswireMRNA LAWSUIT ALERT: The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR NewswireMRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit
PR NewswireMRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireCarisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
PR NewswireModerna, Inc. Class Action: Levi & Korsinsky Reminds Moderna Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA
PR NewswireClass Action Filed Against Moderna, Inc. (MRNA) - October 8, 2024 Deadline to Join - Contact The Gross Law Firm
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNA
PR NewswireLevi & Korsinsky Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNA
PR NewswireLost Money on Moderna, Inc.(MRNA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
PR NewswireThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 8, 2024 in Moderna, Inc. Lawsuit - MRNA
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNA
PR NewswireContact Levi & Korsinsky by October 8, 2024 Deadline to Join Class Action Against Moderna, Inc.(MRNA)
PR NewswireMRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
PR NewswireFlagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
PR NewswireFirst In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration
PR NewswireFlagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders
PR NewswireFlagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
PR NewswireFlagship Pioneering Launches Pioneering Intelligence
PR NewswireCaris Life Sciences and Moderna Announce Multi-Year Strategic Partnership to Advance mRNA-Based Oncology Therapeutics
PR NewswireFlagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer
PR NewswireInvaio achieves first registration for citrus greening solution featuring Trecise™ technology
PR NewswireMODERNA INITIATES ROLLING SUBMISSION TO HEALTH CANADA FOR UPDATED COVID-19 VACCINE
PR NewswireMODERNA INITIATES ROLLING SUBMISSION TO HEALTH CANADA FOR UPDATED COVID-19 VACCINE
PR NewswireFlagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
PR NewswireMODERNA AND NOVOCOL PHARMA ANNOUNCE FILL-FINISH AGREEMENT FOR CANADIAN-MADE MRNA VACCINES
PR NewswireMODERNA AND NOVOCOL PHARMA ANNOUNCE FILL-FINISH AGREEMENT FOR CANADIAN-MADE MRNA VACCINES
RSSForm 4 1682852
RSSForm 4 1682852
Wer­bung

Moderna News

Moderna News: auf dieser Seite finden Sie alle Moderna News und Nachrichten zur Moderna Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Moderna News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Moderna News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.